SURRENINUM (Seroyal USA)


Welcome to the PulseAid listing for the SURRENINUM drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Adrenal gland
SUBSTANCE NAME: ORYCTOLAGUS CUNICULUS ADRENAL GLAND
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: GRANULE
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2017-08-23
END MARKETING DATE: 0000-00-00


SURRENINUM HUMAN OTC DRUG Details:

Item DescriptionSURRENINUM from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 6([hp_X]/1)
START MARKETING DATE: 2017-08-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-7133_577098a5-a9d0-a95f-e053-2a91aa0a92fe
PRODUCT NDC: 62106-7133
APPLICATION NUMBER:

Other ORYCTOLAGUS CUNICULUS ADRENAL GLAND Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USASURRENINUM